Earnings Call · Q2 FY2026·2026-08-13

Q2 26EPS -51.63%·Rev n/aQ1 26EPS +13.89%·Rev n/aQ4 25EPS -11.50%·Rev n/aQ3 25EPS -17.54%·Rev n/a⚠ consensus missing

Karyopharm Therapeutics Inc. KPTI

Anas — Conference Operator

Brendan Strong — Senior Vice President, Investor Relations

Richard — President and Chief Executive Officer

Reshma — Chief Medical Officer

Sohania — Senior Vice President, Commercial

Lori — Chief Financial Officer

−2.0%1d on move date3d−10.8%5d−1.5%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KPTI calls or request research access.

More KPTI calls Browse calls Request research access